1093/N fundamentals
CSPC PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, and profit
The total revenue of 1093/N for the last semiannual is 37.04 B MXN, and it's 10.63% lower compared to the previous semiannual. The net income of H2 24 is 3.81 B MXN.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MXN
TTM